Saturday, August 20, 2016

TAFLOTAN (TAFLUPROST 0.0015%) LAUNCH IN KOTA KINABALU 

Santen Pharmaceutical Ltd., Japan, launched their new prostaglandin analogue, Taflotan, in Kota Kinabalu, Malaysia on 20th August 2016. The launch was accompanied by a talk by Dr Hoh Sek Tien from Mount Novena & Gleneagles Hospital, Singapore. 



at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

AICARDI-GOUTIERES SYNDROME

Aicardi–Goutières syndrome (AGS) is a rare autoimmune neurological disorder belonging to type I interferonopathies.  There are seven subtype...

  • (no title)
    PEARLS FOR CORRECT ASSESSMENT OF THE OPTIC DISC Based on the article by  PROF. BURAK TURGUT and available at the following link: htt...
  • (no title)
    PARAPAPILLARY ATROPHY The Optic Nerve Head (ONH) is often surrounded by different zones of atrophic-like changes occurring in th...
  • (no title)
    AQUEOUS OUTFLOW PATHWAYS Aqueous humor (AH) is produced by the non-pigmented epithelium of the ciliary body. It flows into the post...